1229889

SPI Pharma, Inc. — FEI 2515692

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lewes, DE (United States)